Literature DB >> 1975477

Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons.

H Takahashi1, R G Crystal.   

Abstract

alpha 1-Antitrypsin (alpha 1AT) deficiency, a common hereditary disorder responsible for emphysema in Caucasians of northern European descent, is caused by single base substitutions, deletions, or additions in the seven exons (IA-IC and II-V), of the 12.2-kb alpha 1AT gene located on chromosome 14 at q31-32.3. Of the five known representatives of the "null" group of alpha 1AT-deficiency alleles (alpha 1AT genes incapable of producing alpha 1AT protein detectable in serum) evaluated at the gene level, all result from mutations causing the formation of stop codons in coding exons of the alpha 1AT gene. The present study identifies an alpha 1AT allele (referred to as "Null(isola di procida")) caused by complete deletion of the alpha 1AT coding exons. The Null(isola di procida) allele was identified in an individual with heterozygous inheritance of M(procida) (an allele associated with alpha 1AT deficiency) and a null allele. Although results of karyotypic analysis were normal, quantification of the copies of alpha 1AT genes in this individual revealed that the index case had only half the normal copies of alpha 1AT genes. Cloning and mapping of the Null(isola di procida) gene demonstrated a deletion of a 17-kb fragment that included exons II-V of the alpha 1AT structural gene. As a consequence of the deletion, the normal noncoding exons (IA-IC) were followed by exons II-V of the downstream alpha 1AT-like gene. Sequence analysis of the deletion demonstrated a 7-bp repeat sequence (GAGGACA) both 5' to the deletion and at the 3' end of the deletion, a 4-bp palindromic sequence (ACAG vs. CTGT) bracketing the deletion, and a novel inserted 4-bp sequence (CCTG) at the breakpoint, suggesting that the mechanism of the deletion may have been "slipped mispairing."

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975477      PMCID: PMC1683852     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  51 in total

1.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

2.  Genetic studies of the lac repressor. VII. On the molecular nature of spontaneous hotspots in the lacI gene of Escherichia coli.

Authors:  P J Farabaugh; U Schmeissner; M Hofer; J H Miller
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

3.  Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.

Authors:  M D Wewers; M A Casolaro; S E Sellers; S C Swayze; K M McPhaul; J T Wittes; R G Crystal
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

4.  Improved resolution of PI (alpha 1-antitrypsin) phenotypes by a large-scale immobilized pH gradient.

Authors:  A Görg; W Postel; J Weser; W Patutschnick; H Cleve
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

Review 5.  The mutation and polymorphism of the human beta-globin gene and its surrounding DNA.

Authors:  S H Orkin; H H Kazazian
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

Review 6.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis.

Authors:  A Janoff
Journal:  Am Rev Respir Dis       Date:  1985-08

7.  A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids.

Authors:  J P Michalski; C C McCombs; S Sheth; M McCarthy; R deShazo
Journal:  J Immunol Methods       Date:  1985-10-24       Impact factor: 2.303

8.  Deletion 14q(q24.3 to q32.1) syndrome: significance of peculiar facial appearance in its diagnosis, and deletion mapping of Pi(alpha 1-antitrypsin).

Authors:  Y Yamamoto; R Sawa; N Okamoto; A Matsui; M Yanagisawa; S Ikemoto
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

9.  Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes.

Authors:  R I Garver; J F Mornex; T Nukiwa; M Brantly; M Courtney; J P LeCocq; R G Crystal
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

10.  Regional location of alpha 1-antichymotrypsin and alpha 1-antitrypsin genes on human chromosome 14.

Authors:  M Rabin; M Watson; V Kidd; S L Woo; W R Breg; F H Ruddle
Journal:  Somat Cell Mol Genet       Date:  1986-03
View more
  7 in total

1.  Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency.

Authors:  Roberto Calcedo; Suryanarayan Somanathan; Qiuyue Qin; Michael R Betts; Andrew J Rech; Robert H Vonderheide; Christian Mueller; Terence R Flotte; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 2.  Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk.

Authors:  D L DeMeo; E K Silverman
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

Review 3.  Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Authors:  Jennifer A Dickens; David A Lomas
Journal:  Drug Des Devel Ther       Date:  2011-08-17       Impact factor: 4.162

4.  Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism.

Authors:  Katrin Milger; Lesca Miriam Holdt; Daniel Teupser; Rudolf Maria Huber; Jürgen Behr; Nikolaus Kneidinger
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-07

5.  Identification and characterisation of eight novel SERPINA1 Null mutations.

Authors:  Ilaria Ferrarotti; Tomás P Carroll; Stefania Ottaviani; Anna M Fra; Geraldine O'Brien; Kevin Molloy; Luciano Corda; Daniela Medicina; David R Curran; Noel G McElvaney; Maurizio Luisetti
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

6.  Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.

Authors:  Philippe Joly; Olivier Guillaud; Valérie Hervieu; Alain Francina; Jean-François Mornex; Colette Chapuis-Cellier
Journal:  Orphanet J Rare Dis       Date:  2015-10-07       Impact factor: 4.123

7.  Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid.

Authors:  Beatriz Lara; Maria Teresa Martínez; Ignacio Blanco; Cristina Hernández-Moro; Eladio A Velasco; Ilaria Ferrarotti; Francisco Rodriguez-Frias; Laura Perez; Irene Vazquez; Javier Alonso; Manuel Posada; Beatriz Martínez-Delgado
Journal:  Respir Res       Date:  2014-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.